Evidence map›Paper›PMID 26095115›Full record

ReviewNeurogastroenterology and motility2015

Serotonin and colonic motility.

D M Kendig, J R Grider

Open access · greenAbstract readReview
In one paragraph

Review in Neurogastroenterology and motility, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Review
  3. Prokinetic drugs that stimulate 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Mechanisms and clinical implications of gut-brain interactions.The Journal of clinical investigation · 2026
    Review
  8. Tryptophan's Journey Through Pregnancy: The Role of Serotonin.International journal of tryptophan research : IJTR · 2026
    Review
  9. Article
  10. Review
  11. A Frank Assessment of SHANK: Impacts of Pathogenic Variations in SHANK3 on Preclinical Models of Phelan McDermid Syndrome.Autism research : official journal of the International Society for Autism Research · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

D M KendigVirginia Commonwealth University Program in Enteric Neuromuscular Sciences, Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA, USA.
J R GriderVirginia Commonwealth University Program in Enteric Neuromuscular Sciences, Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA, USA.
Virginia Commonwealth University · US

Funding

Virginia Commonwealth University IRADCAK12GM093857 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI DANIEL C BULLARD, John J Ryan · 2010 to 2026
$7.0M
ROLE OF GUT PEPTIDES IN INTESTINAL PERISTALSISR01DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 1987 to 2019
$5.5M
Role of Gut Peptides in Intestinal PeristalsisR56DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 2009 to 2009
$351k
ROLE OF GUT PEPTIDES IN INTESTINAL PERISTALSISR23DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 1986 to 1986
–
NIDDK NIH HHS DK34153NIDDK NIH HHS R01 DK034153NIDDK NIH HHS R56 DK034153NIGMS NIH HHS K12 GM093857NIGMS NIH HHS K12GM093857
6 · The paper itself

Abstract

The role of serotonin (5-hydroxytryptamine [5-HT]) in gastrointestinal motility has been studied for over 50 years. Most of the 5-HT in the body resides in the gut wall, where it is located in subsets of mucosal cells (enterochromaffin cells) and neurons (descending interneurons). Many studies suggest that 5-HT is important to normal and dysfunctional gut motility and drugs affecting 5-HT receptors, especially 5-HT3 and 5-HT4 receptors, have been used clinically to treat motility disorders; however, cardiovascular side effects have limited the use of these drugs. Recently studies have questioned the importance and necessity of 5-HT in general and mucosal 5-HT in particular for colonic motility. Recent evidence suggests the importance of 5-HT3 and 5-HT4 receptors for initiation and generation of one of the key colonic motility patterns, the colonic migrating motor complex (CMMC), in rat. The findings suggest that 5-HT3 and 5-HT4 receptors are differentially involved in two different types of rat CMMCs: the long distance contraction (LDC) and the rhythmic propulsive motor complex (RPMC). The understanding of the role of serotonin in colonic motility has been influenced by the specific motility pattern(s) studied, the stimulus used to initiate the motility (spontaneous vs induced), and the route of administration of drugs. All of these considerations contribute to the understanding and the controversy that continues to surround the role of serotonin in the gut.

Indexed as

AnimalsColonGastrointestinal MotilityIntestinal MucosaRatsSerotoninSerotonin5-HT receptors5-hydroxytryptaminecolonic migrating motor complexmotility reflexesrat colon

Identifiers

PMID26095115
PMCPMC4477275
OpenAlexW1597626394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.